ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Gynecologic Oncology
Volume 106, Issue 1, July 2007, Pages 119-127
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (1876 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.ygyno.2007.03.039    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2007 Elsevier Inc. All rights reserved.

B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration

Takashi Miyatakea, Barbara Tringlera, Wenhui Liub, Shu-Hui Liub, Jackie Papkoffb, Takayuki Enomotoc, Kathleen C. Torkkoa, Donna L. Dehna, Ashanta Swishera and Kenneth R. Shroyera, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Pathology, University of Colorado at Denver and Health Sciences Center, 12800 E.19th Ave. Aurora, CO 80010, USA bCFD Therapeutics, Inc, 343 Oyster Point Blvd., South San Francisco, CA 94080, USA cDepartment of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan

Received 27 November 2006. 
Available online 16 May 2007.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Objectives and methods

B7-H4 (DD-O110), a member of the B7 family, negatively regulates T cell-mediated immune response. Previous studies have shown that B7-H4 is highly expressed in endometrioid ovarian cancers with relatively low levels of expression in normal ovary which was confirmed by Western blot. The present study was designed to localize B7-H4 expression by immunohistochemistry (IHC) in normal endometrium, endometrial hyperplasia and uterine endometrioid adenocarcinoma. The pattern of B7-H4 localization was compared with the IHC detection of CD3 and CD8-positive T lymphocytes and CD14 positive macrophages to investigate the role of B7-H4 in the regulation of tumor immune surveillance. B7-H4 expression was evaluated in apoptotic tumor cells.

Results

The proportion and intensity of B7-H4 staining were increased in the progression from normal, hyperplastic and malignant endometrial glandular mucosa. B7-H4 showed a predominantly apical membranous staining (pattern 1) in normal and hyperplastic endometrial epithelium but showed intense circumferential membranous and cytoplasmic staining (pattern 2) in a majority of endometrioid carcinoma cases (p = 0.018). The proportion of B7-H4 positive tumor cells and staining intensity was also higher in high risk tumors than in low risk tumors (p = 0.001 and p = 0.032, respectively). The proportion of B7-H4 positive tumor cells was inversely related to the number of CD3-positive and CD8-positive tumor-associated lymphocytes (TALs). There was a positive correlation between B7-H4 pattern 2 staining and both CD3-positive and CD8-positive tumor-infiltrating lymphocytes (TILs) (p = 0.039 and p = 0.031, respectively).

Conclusions

B7-H4 is overexpressed in hyperplastic and malignant endometrial epithelium and is correlated with the number T cells associated with the tumor. These results suggest that B7-H4 overexpression may reflect a more aggressive biologic potential and may play a role in tumor immune surveillance mechanisms.

Keywords: Endometrial carcinoma; Endometrioid cancer; B7-H4; immunohistochemistry; biomarker; tumor immune surveillance

Article Outline

Introduction
Materials and methods
Tissue samples
Western blot analysis
Immunohistochemistry
Evaluation of staining
Statistical analysis
Results
Western blot analysis
B7-H4 expression in normal cycling endometrium, endometrial hyperplasia and endometrioid adenocarcinoma
Correlation of B7-H4 expression and tumor T-cell infiltration
Correlation of B7-H4 expression with detection of tumor macrophages
Discussion
Acknowledgements
References








Gynecologic Oncology
Volume 106, Issue 1, July 2007, Pages 119-127
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.